Sunday August 20th 2017

Archive for May, 2016

Monthly News Roundup – May 2016

Monthly News Roundup – May 2016

FDA Approves Zinbryta for Multiple Sclerosis Multiple sclerosis, a chronic, inflammatory, autoimmune disease of the central nervous system, has been reported as the leading cause of disability in young adults 20 to 40 years of age. The US Food... (Source: Drugs.com - Pharma [Read More]

GeNeuro begins treatment in Phase llb trial of GNbAC1 to treat RRMS

GeNeuro begins treatment in Phase llb trial of GNbAC1 to treat RRMS

Swiss-based, biopharmaceutical company GeNeuro has started treating patients in a Phase IIb trial of GNbAC1 for the treatment of relapsing-remitting multiple sclerosis (RRMS). (Source: Drug Development Technology) [Read More]

Biogen’s new MS drug approved by FDA will be made in RTP

Biogen’s new MS drug approved by FDA will be made in RTP

The long-acting multiple sclerosis treatment that the U.S. Food and Drug Administration approved late last week will be manufactured in Research Triangle Park. The drug, Zinbryta, will be manufactured by Biogen (Nasdaq: BIIB), which is based in Cambridge, Massachusetts, and [Read More]

 Page 1 of 32  1  2  3  4  5 » ...  Last »